Pusan National University researchers identify the brain enzyme that drives nicotine addiction and smoking dependence
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Dec-2025 08:11 ET (22-Dec-2025 13:11 GMT/UTC)
Nicotine addiction remains one of the most persistent global health challenges, yet the cellular mechanisms underlying it are less explored. Now, researchers have discovered that astrocytes, glial cells in the brain thought to play only a passive role, actively contribute to the brain changes triggered by repeated nicotine exposure. The findings provide insights into nicotine-induced changes in the brain by an enzyme that regulates a key glutamate-related pathway linked to sensitized behavior.
A new study uncovers a crucial molecular pathway that enables endometrial cells to survive oxidative stress, fueling endometriosis progression. Researchers found the CHK1/SGK1 axis plays a pivotal role in promoting cell survival and aging resistance, presenting promising therapeutic targets. Antioxidants and CHK1/SGK1 specific inhibitors demonstrated potential in reducing lesions, offering hope for improved treatments on endometriosis.
A novel treatment (MA-5) developed by a Tohoku University-led research team will soon undergo phase II clinical trials at four medical institutions across Japan. MA-5 could provide hope for patients with mitochondrial diseases – as there are currently no approved treatments available.
For the first time, a new high-resolution microscopy technique has allowed researchers to watch live as influenza viruses infect cells.
The international team led by ETH Zurich found that the cells actively promote virus uptake.
This technique could now help to develop antiviral therapies in a more targeted manner.